Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06064916 · ClinicalTrials.gov registry record

Visual Outcomes and Patient Satisfaction With Vivity IOL in Post Refractive Patients

A clinical trial, sponsored by Berkeley Eye Center.

Completed
Registry status
20
Enrollment target

NCT06064916: Completed study, sponsored by Berkeley Eye Center.

NCT06064916 is a clinical trial that has completed, run by Berkeley Eye Center. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06064916 has completed, sponsored by Berkeley Eye Center.

COMPLETED
Registry status
20 participants
Enrollment target

Study Summary

This is a non-interventional, prospective, observational study of the outcomes for post myopic refractive surgery patients following successful, uncomplicated cataract surgery with bilateral implantation of the Vivity IOL (DAT\*\*\*/CCWET\*). Patients will be assessed for monocular and binocular distance, intermediate, and near vision.

Primary Outcome

Binocular Best Corrected Distance Visual Acuity in logMAR

Interventions

  • DIAGNOSTIC_TEST Visual Acuity
  • DIAGNOSTIC_TEST Defocus Curve
  • OTHER Intraocular Lens Satisfaction (IOLSAT) Questionnaire
  • OTHER Quality of Vision After Surgery (QUVID) Questionnaire
  • OTHER Visual Disturbance Questionnaire

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2023-07-25
Est. Completion 2024-12-11
Berkeley Eye Center

8 total trials

What the finished NCT06064916 record still lists

NCT06064916 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.

The record links to 0 conditions, and to 5 interventions - of which Visual Acuity is the first listed.

NCT06064916 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT06064916 about?

NCT06064916 is a clinical study titled "Visual Outcomes and Patient Satisfaction With Vivity IOL in Post Refractive Patients". This is a non-interventional, prospective, observational study of the outcomes for post myopic refractive surgery patients following successful, uncomplicated cataract surgery with bilateral implantation of the Vivity IOL (DAT\*\*\*/CCWET\*). Patients will be assessed for monocular and binocular di...

What is the current status of trial NCT06064916?

This trial is currently completed. The enrollment target is 20 participants. The study started on 2023-07-25. Estimated completion is 2024-12-11.

What interventions are being tested in trial NCT06064916?

The interventions under investigation include: Visual Acuity (DIAGNOSTIC_TEST), Defocus Curve (DIAGNOSTIC_TEST), Intraocular Lens Satisfaction (IOLSAT) Questionnaire (OTHER), Quality of Vision After Surgery (QUVID) Questionnaire (OTHER), Visual Disturbance Questionnaire (OTHER).

Who is sponsoring clinical trial NCT06064916?

This trial is sponsored by Berkeley Eye Center, which has 8 total clinical trials registered on ClinicalTrials.gov.

Learn More About Clinical Trials

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06064916, the US trial registry maintained by the National Library of Medicine. NCT06064916 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.